Skip to main navigation Skip to search Skip to main content

Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science